mature lymphoid neoplasm Flashcards

(51 cards)

1
Q

disorders in which the localization of disease
is in the
___ are
considered

A

lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lymphoproliferative disorders in which the
primary site of disease is the _______ are classified as leukemias;

A

Lymphoproliferative disorders in which the
primary site of disease is the blood or bone
marrow are classified as leukemias;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

tend to be bone
marrow based, although extramedullary
involvement may be an important part of the
clinical presentation

A

Plasma cell neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

are recognized as B cell disorders,
although the normal counterpart of the
transformed cells remains elusive.

A

Hodgkin lymphoma and hairy cell leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

“cobblestone” or likened to a
soccer ball chromatin pattern

A

Chronic Lymphocytic Leukemia (CLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Smudged lymphocytes

A

cll

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLL lymphocytes exhibit__________.

A

B cell markers
= CD19, CD20, and CD23
T cell antigen = CD5.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

abnormalities are
among the worst prognostic indicators and
foretell
resistance
to
chemoimmunotherapy approaches

A

Del(17p) and TP53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

expressions are cell
markers that generally correlate with IGHv
mutational status but also have independent
prognostic value

A

CD38 and ZAP70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

most powerful prognostic factor of CLL is the

A

immunoglobulin genes (IGHv)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chronic Lymphocytic Leukemia (CLL)

A

● oral alkylating agents such as chlorambucil or
cyclophosphamide.
● nucleoside analog fludarabine and rituximab
● BTK inhibitors (ibrutinib), PI3k inhibitors
(idelalisib), and BCL2 inhibitors (venetoclax)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

asymptomatic, without any lymphadenopathy,
organomegaly, cytopenias, or systemic
symptoms with less than 5x10^9/L circulating
B lymphocytes

A

MONOCLONAL B CELL LYMPHOCYTOSIS
(MBL) AND SMALL LYMPHOCYTIC LYMPHO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

disease of the elderly, with a median age of
approximately 70 years AND AN equal
distribution between the sexes.

A

PROLYMPHOCYTIC LYMPHOMA (PLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

characterized by massive splenomegaly and
marked absolute lymphocytosis, often more
than 100 10^9/L

A

PROLYMPHOCYTIC LYMPHOMA (PLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

the presence of at least 5 10^9 cells/L of
circulating B lymphocytes for more than 3
months to establish the diagnosis of ____,
with confirmation of clonality performed by
flow cytometry

A

CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pll tx

A

● PLL has been treated with a standard
lymphoma regimen, such as CHOP
(cyclophosphamide, doxorubicin, vincristine,
and prednisone).
● The anti-CD52 monoclonal antibody alemtu
zumab has been used for the T cell subtype
of PLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

● presence of marrow fibrosis
● Pat terns of bone marrow involvement may
be interstitial or patchy
● Hairy cells are found in the peripheral blood
and bone mar row aspirate,

A

HAIRY CELL LEUKEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

rare disease characterized by an increase in
circulating LGLs in excess of 2 10^9/L

A

LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

● may trigger a variant/atypical lymphocyte flag
or blast flag
● Most patients present with neutropenia,
anemia, or both

A

LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

is a clonal expansion of
cytotoxic T cells, expressing CD3,
CD8, and CD57.

A

T cell LGL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

in creased numbers of
clonal NK cells in circulation. they/re
typically negative for CD3 but do
express CD56

A

The other form of LGL leukemia is categorized as a chronic lymphoproliferative disorder of NK cells,

22
Q

LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

A

● Myeloid growth factors
● immunosuppressive agents, such as low
doses of methotrexate, cyclophosphamide,
or cyclosporin A,

23
Q

post-thymic neo plastic disorder of T cells
associated with retroviral infection by the
human T lymphotropic virus type 1 (HTLV-1)

A

ADULT T CELL LEUKEMIA/LYMPHOMA

24
Q

● latency period of 55 to 70 years.

A

ADULT T CELL LEUKEMIA/LYMPHOMA

25
This disease has an aggressive clinical course marked by extensive extranodal involvement of the peripheral blood and skin.
ADULT T CELL LEUKEMIA/LYMPHOMA
26
Complications of tumor involvement include osteolytic lesions, hypercalcemia, and profound immunosuppression resulting in infection
ADULT T CELL LEUKEMIA/LYMPHO
27
Complications of tumor involvement include osteolytic lesions, hypercalcemia, and profound immunosuppression resulting in infection
ADULT T CELL LEUKEMIA/LYMPHOMA
28
“flower cell”
ADULT T CELL LEUKEMIA/LYMPHOMA
29
malignant cells may be smaller with a pleomorphic appearance reminiscent of other peripheral T cell lymphomas, such as Sézary syndrome
ADULT T CELL LEUKEMIA/LYMPHOMA
30
cd of t cell leukemia
CD3 and CD4 are expressed, whereas CD7 and CD8 are absent. CD25 and CCR4 are also highly expressed.
31
combination of interferon alpha and azidothymidine has been reported to have some efficacy against the HTLV-1 virus.
32
aggressive cancer of mature B cells associated with a fulminant clinical presentation.
BURKITT LEUKEMIA/LYMPHOMA
33
BL has three subtypes:
endemic, sporadic, and HIV associated. ○ Endemic - found primarily i geographic distribution similar to that of malaria. ○ Sporadic - abdominal disease. ○ HIV associated - immunosuppression. Unlike in other subtypes, the blood and bone marrow are primary sites of disease.
34
extranodal involvement is common, with the orbits and mandible as typical sites of disease
BURKITT LEUKEMIA/LYMPHOMA
35
EBV genome has been found to be present in the neoplastic cells.
BURKITT LEUKEMIA/LYMPHOMA
36
“starry sky” appearance, which results from the interspersed tingible body macrophages suspended in a “sea” of malignant cells
BURKITT LEUKEMIA/LYMPHOMa
37
cd of burkitt
expression of CD10 and the absence of immature markers, such as CD34 or Tdt.
38
Due to high cell turnover tumor lysis syndrome should be anticipated, and supportive efforts intravenous (IV) antihiperurisemia with aggressive hydration medications and are indicated prior to the start of cytotoxic chemotherapy
BL
39
● neoplastic disorder of germinal B cells
FOLLICULAR LYMPHOMA
40
The clinical pattern is one of serial responses to chemotherapy followed by recurring relapse until death
FOLLICULAR LYMPHOMA
41
FL cells appear
small and irregular with an angular appearance (centrocytes) larger with round to ovoid nuclei containing one to three nucleoli located on the border within the nucleus (centroblasts)
42
Most patients present with extensive lymphadenopathy.
MANTLE CELL LYMPHOMA
43
the indolent form tend to have the disease restricted to the blood, bone marrow, and spleen.
MANTLE CELL LYMPHOMA
44
A blastoid variant of MCL with pleomorphic, immature features can be confused with
acute lymphoid leukemia or diffuse large cell lymphoma
45
The small cell form of MCL can easily be mistaken for
CLL/SLL or marginal zone lymphoma
46
accurate diagnosis of MCL requires
○ demonstration of either t(11,14) via FISH or overexpression of cyclin D1 by immunohistochemistry. ○ Expression of SOX11, a transcription factor, is used to diagnose the 5% of cases that are cyclin D1 negative
47
48
can arise de novo or result as a transformation from a more indolent form of lymphoma, such as CLL/SLL, FL, or MZL.
DIFFUSE LARGE B CELL LYMPHOMA
49
Extranodal involvement can occur in the GI tract, testis, or bone.
DIFFUSE LARGE B CELL LYMPHOMA
50
abnormalities – these cases have been labeled “double (or tri ple) hit” lymphoma and have an exceptionally poor prognosis.
BCL2 and/or BCL6
51